INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 435m ago
House PTR35m ago
SEC 13F34m ago
Robinhood Chain34m ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,558 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Grant or award
A—
155.0K sh
Jan 30, 2026Feb 2, 2026
Page 1391 of 1814
← PrevNext →
traded Jan 30, 2026
+3d
SEC Form 4

Evidence

13
GD
Garesche Donna DEVP, Chief HR Officer
BXPBXP, Inc.
Grant or award
A$850
3,401 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

13
KD
Keefauver DavidEVP of People
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$40K
198 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

13
TJ
Trahan JeremyGeneral Counsel
VMDVIEMED HEALTHCARE, INC.
Disposition to issuer
D$27K
3,591 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

13
TJ
Trahan JeremyGeneral Counsel
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
3,591 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

13
AB
Adachi BarbaraDirector
ORIOLD REPUBLIC INTERNATIONAL CORP
Tax withholding
F$37K
958 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

13
KG
Kevorkian Eric GSVP, CLO and Secretary
BXPBXP, Inc.
Grant or award
A$957
3,827 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

13
KD
Keefauver DavidEVP of People
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
420 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

13
HK
Henderson Tracey KExecutive VP Exploration
APAAPA Corp
Option exercise
M—
6,158 sh
Feb 1, 2026Feb 2, 2026
traded Feb 1, 2026
+1dSEC Form 4

Evidence

13
KG
Kevorkian Eric GSVP, CLO of GP
NANABOSTON PROPERTIES LTD PARTNERSHIP
Grant or award
A$957
3,827 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

13
MD
Maddox Mark DExecutive VP - Administration
APAAPA Corp
Option exercise
M—
6,158 sh
Feb 1, 2026Feb 2, 2026
traded Feb 1, 2026
+1dSEC Form 4

Evidence

12
MD
Maddox Mark DExecutive VP - Administration
APAAPA Corp
Tax withholding
F$64K
2,424 sh
Feb 1, 2026Feb 2, 2026
traded Feb 1, 2026
+1dSEC Form 4

Evidence

12
DB
Delco Albert BradEVP & CFO
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$134K
660 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

12
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$201K
27.3K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

12
MT
Millwood TimothySVP Chief Supply Chain Officer
AGCOAGCO CORP /DE
Tax withholding
F$50K
444 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

12
MT
Millwood TimothySVP Chief Supply Chain Officer
AGCOAGCO CORP /DE
Tax withholding
F$67K
586 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

11
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
11.3K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

11
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
11.3K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

11
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$504K
68.5K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

11
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
11.3K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

10
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$78K
7,500 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
CD
Conn Avi DanielChief Financial Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
45.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
RR
Ross Scott RichardEVP & CIO
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
17.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
KE
Krohne Susan EChief Legal Officer, Secretary
MHOM/I HOMES, INC.
Option exercise
M—
5,000 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
HH
Harris Isaac HosojiroDirector, SEE REMARKS
LITELumentum Holdings Inc.
Grant or award
A—
629 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
CL
Contreras Lerdo de Tejada LeonardoDirector
SCCOSOUTHERN COPPER CORP/
Grant or award
A—
200 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
SN
Steele NicolaChief Operating Officer
DNUTKrispy Kreme, Inc.
Grant or award
A—
1,382 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
KD
Kauh John Saewook M.D.Chief Medical Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
45.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
MJ
Merz Mark JosephSVP OF INTERNATIONAL
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
3,368 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
AJ
Arrigunaga Gomez del Campo JavierDirector
SCCOSOUTHERN COPPER CORP/
Grant or award
A—
200 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
SK
Slupkowski KrzysztofChief Credit Officer
EQBKEQUITY BANCSHARES INC
Tax withholding
F$3,655
79 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
DR
Duvivier RaphaelChief Financial Officer
DNUTKrispy Kreme, Inc.
Tax withholding
F$2,054
650 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
HM
Harris Ivory MarieSVP Chief HR Officer
AGCOAGCO CORP /DE
Tax withholding
F$48K
416 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
TB
Tadele BeimnetEVP & President, Restaurants
VYXNCR Voyix Corp
Option exercise
M—
4,941 sh
Feb 1, 2026Feb 2, 2026
traded Feb 1, 2026
+1dSEC Form 4

Evidence

9
CJ
Charlesworth JoshDirector, President & CEO
DNUTKrispy Kreme, Inc.
Tax withholding
F$3,106
983 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
HA
Holder AlisonChief Brand & Product Officer
DNUTKrispy Kreme, Inc.
Tax withholding
F$1,229
389 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
VP
Valenzuela Rionda Jose PedroDirector
SCCOSOUTHERN COPPER CORP/
Grant or award
A—
200 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
MA
Mayer Jeffrey AlanDirector
NONENONEPIMCO Asset-Based Lending Co LLC
Grant or award
A—
2,834 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
MT
Millwood TimothySVP Chief Supply Chain Officer
AGCOAGCO CORP /DE
Tax withholding
F$34K
296 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
CL
Chi LisaSEE REMARKS
RHRH
Option exercise
M—
6,000 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence